BSX
NYSE Boston Scientific Corporation$44.00 ↑ +0.12 (+0.27%) Trading Up from the previous close of $43.88
- YTD change
- -53.86%
- vs 20-day SMA
- -1.87%
- vs 200-day SMA
- -29.57%
Price ranges
Price & Performance
-19.05 (-30.27%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 59.8% away from all-time highs of $109.50
- BSX is down 54% since the beginning of the year
- BSX is down 55% over the past 12 months
- BSX is down 9% over the past 1 month
- 3% of all BSX investors are betting against BSX
- Number of investors short BSX has gone up 109% versus last month
BSX reads not so good: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -55.1%.
- Previous minute
- +$0.15
- Last hour
- +$0.07
- Last 5 days
- -2.05%
- vs 8-day SMA
- -0.34%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
